Log In
BCIQ
Print this Print this
 

fluticasone furoate/umeclidinium

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionFixed-dose inhaled formulation of a corticosteroid and long-acting muscarinic antagonist (LAMA)
Molecular Target Glucocorticoid receptor (GCCR) ; Muscarinic receptor
Mechanism of ActionMuscarinic receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationAsthma
Indication DetailsTreat asthma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today